3P Biopharmaceuticals among the 100 best companies to work for in Spain
Biovian Announces the Appointment of a New Board Member − Dr. Uwe Gottschalk
3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.
3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial.
3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra
Viral safety in viral vector applications – what you need to know?
3P Biopharmaceuticals makes a significant donation to help Ukraine
Dámaso Molero, appointed member of the Technical Committee of the Interdepartmental Commission for Personalized Medicine of Navarra.
ANLBIO selected Biovian for manufacturing of AAV-based product for the treatment of Alzheimer’s disease.
Support functions at Biovian – warehousing, purchasing, and sterile supply management.
Elena Erroba, winner of the Navarra 2021 Management Award organised by AMEDNA-NEEZE
3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA
3P Biopharmaceuticals enters into alliance with Precirix to develop precision radiopharmaceuticals in oncology
3P Biopharmaceuticals receives FDA approval
